Novavax, Inc. (NVAX)
10.64
+0.56
(+5.56%)
USD |
NASDAQ |
Mar 17, 16:00
10.63
-0.01
(-0.09%)
After-Hours: 20:00
Novavax Profit Margin (Quarterly) : 11.91% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -9.34% |
| Moderna, Inc. | -121.8% |
| Merck & Co., Inc. | 18.15% |
| Intellia Therapeutics, Inc. | -416.2% |
| Recursion Pharmaceuticals, Inc. | -304.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 33.38% |
| Return on Invested Capital | 725.3% |
| Gross Profit Margin (Quarterly) | 82.87% |
| Operating Margin (Quarterly) | 14.29% |
| Return on Net Operating Assets | 97.45% |